| Literature DB >> 26440674 |
Hucheng Zhu1, Chunmei Chen1, Qingyi Tong1, Xintao Chen1, Jing Yang2, Junjun Liu1, Bin Sun1, Jianping Wang1, Guangmin Yao1, Zengwei Luo1, Yongbo Xue1, Yonghui Zhang1.
Abstract
Six new polycyclic polyprenylated acylphloroglucinols (PPAPs), named hyperisampsins H-M (1-6), were isolated from the aerial parts of Hypericum sampsonii, together with five known analogs (7-11). The structures of 1-6 were established by extensive spectroscopic analyses, including HRESIMS and NMR. In addition, the absolute configurations of these new compounds were determined by electronic circular dichroism (ECD) calculations. Compounds 1 and 2 represent the first examples of PPAPs possessing a unique γ-lactone ring at C-23, while 3-6 differed from normal PPAPs with an unprecedented 1,2-dioxane ring. Compounds 1-7 were evaluated for their cytotoxic activities against a panel of human cancer cell lines in vitro, of which 3, 4, and 6 exhibited significant cytotoxic activities with IC50 values ranging from 0.56 to 3.00 μM. Moreover, compound 3 induces leukemia cell apoptotic death, evidenced by activation of caspase-3, degradation of PARP, up-regulation of Bax, and down-regulation of Bcl-2 and Bcl-xl.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26440674 PMCID: PMC4594001 DOI: 10.1038/srep14772
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Structures of isolated compounds.
1H NMR Data for Compounds 1–6 in CDCl3 (400 MHz, J in Hz).
| 1 | 2 | 3 | 4 | 5 | 6 | |
|---|---|---|---|---|---|---|
| 6 | 2.29 d (14.1) | 2.34 d (14.1) | 2.30 d (14.1) | 2.30 d (14.2) | 2.36 d (14.1) | 2.31 d (14.1) |
| 6 | 2.19 dd (14.1, 7.3) | 2.18 dd (14.1, 7.5) | 2.16 m | 2.16 m | 2.22 m | 2.18 m |
| 7 | 1.50 m | 1.51 m | 1.50 m | 1.48 m | 1.56 m | 1.51 m |
| 12 | 7.43 d (8.2) | 7.44 d (8.2) | 7.45 d (7.4) | 7.45 d (8.0) | 7.51 d (7.3) | 7.46 d (8.5) |
| 13 | 7.27 t (7.6) | 7.23 t (7.8) | 7.21 t (7.8) | 7.22 t (7.8) | 7.27 t (7.8) | 7.21 t (7.8) |
| 14 | 7.38 t (7.3) | 7.39 t (7.4) | 7.38 t (7.4) | 7.38 t (7.4) | 7.44 t (7.4) | 7.38 t (7.4) |
| 15 | 7.27 t (7.6) | 7.23 t (7.8) | 7.21 t (7.8) | 7.22 t (7.8) | 7.27 t (7.8) | 7.21 t (7.8) |
| 16 | 7.43 d (8.2) | 7.44 d (8.2) | 7.45 d (7.4) | 7.45 d (8.0) | 7.51 d (7.3) | 7.46 d (8.5) |
| 17 | 3.09 dd (14.2, 7.9) | 3.07 dd (14.2, 7.0) | 3.08 dd (13.9, 7.4) | 3.08 dd (13.9, 7.4) | 3.13 dd (14.2, 7.5) | 3.08 dd (13.9, 7.7) |
| 17 | 2.91 m | 2.97 dd (14.2, 7.6) | 3.00 dd (13.9, 7.8) | 3.00 dd (13.9, 7.9) | 3.05 dd (14.2, 7.6) | 3.01 dd (13.9, 7.7) |
| 18 | 4.95 t (7.2) | 4.94 t (7.0) | 5.07 t (7.6) | 5.07 t (7.5) | 5.11 t (7.5) | 5.05 t (7.7) |
| 20 | 1.58 s | 1.60 s | 1.61 s | 1.61 s | 1.65 s | 1.60 s |
| 21 | 1.56 s | 1.60 s | 1.63 s | 1.63 s | 1.66 s | 1.61 s |
| 22 | 2.88 m | 2.46 dd (13.3, 11.1) | 2.63 dd (13.3, 11.0) | 2.64 dd (13.3, 10.8) | 2.65 dd (13.3, 10.9) | 2.58 dd (13.3, 11.0) |
| 22 | 1.91 dd (13.3, 6.1) | 1.92 dd (13.3, 5.8) | 1.86 dd (13.3, 5.8) | 1.86 m | 1.90 m | 1.86 dd (13.3, 6.1) |
| 23 | 4.72 dd (10.3, 6.1) | 4.88 dd (11.1, 5.8) | 4.67 dd (11.0, 5.9) | 4.65 dd (10.8, 5.8) | 4.78 m | 4.75 m |
| 25 | 2.54 dd (13.1, 2.2) | 2.14 m | 1.88 m | 1.88 m | 1.88 m | 1.81 m |
| 25 | 2.16 m | 2.01 dt (13.2, 8.4) | 1.81 m | 1.78 m | 1.72 m | 1.66 m |
| 26 | 1.45 s | 1.47 s | 1.35 s | 1.37 s | 1.37 s | 1.31 s |
| 27 | 2.79 m | 2.69 t (8.4) | 1.97 m | 1.87 m | 1.90 m | 1.96 m |
| 27 | 2.66 m | 1.82 m | 1.62 m | 1.81 m | ||
| 28 | 3.91 dd (10.6, 3.2) | 4.27 dd (9.7, 3.2) | 4.29 dd (10.8, 3.2) | 3.88 dd (11.0, 3.5) | ||
| 30 | 1.23 s | 1.27 s | 1.32 s | 1.23 s | ||
| 31 | 1.27 s | 1.28 s | 1.38 s | 1.28 s | ||
| 32 | 2.16 m | 2.14 m | 2.16 m | 2.16 m | 2.22 m | 2.18 m |
| 33 | 4.88 t (7.1) | 4.87 t (7.5) | 4.87 t (7.2) | 4.87 t (7.2) | 4.93 t (7.2) | 4.87 t (7.1) |
| 35 | 1.69 s | 1.69 s | 1.69 s | 1.69 s | 1.66 s | 1.69 s |
| 36 | 1.54 s | 1.53 s | 1.54 s | 1.53 s | 1.75 s | 1.54 s |
| 37 | 1.48 s | 1.48 s | 1.48 s | 1.47 s | 1.59 s | 1.49 s |
| 38 | 1.40 s | 1.41 s | 1.40 s | 1.40 s | 1.45 s | 1.40 s |
13C NMR Data for Compounds 1–6 in CDCl3 (100 MHz).
| 1 | 2 | 3 | 4 | 5 | 6 | 1 | 2 | 3 | 4 | 5 | 6 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 76.9 | 77.2 | 77.2 | 77.2 | 77.7 | 77.1 | 20 | 25.6 | 25.8 | 25.8 | 25.8 | 25.8 | 25.8 |
| 2 | 193.8 | 193.7 | 193.8 | 193.9 | 193.8 | 193.7 | 21 | 17.7 | 17.7 | 17.8 | 17.8 | 17.8 | 17.8 |
| 3 | 116.0 | 116.2 | 115.8 | 115.8 | 115.8 | 115.8 | 22 | 31.1 | 31.8 | 31.0 | 30.9 | 31.0 | 31.1 |
| 4 | 171.4 | 171.5 | 172.2 | 172.2 | 172.6 | 172.2 | 23 | 88.3 | 87.0 | 87.1 | 87.1 | 86.8 | 86.7 |
| 5 | 58.4 | 58.4 | 58.2 | 58.2 | 58.2 | 58.2 | 24 | 84.1 | 85.7 | 80.9 | 80.9 | 81.5 | 81.7 |
| 6 | 36.9 | 36.4 | 36.5 | 36.5 | 36.7 | 36.6 | 25 | 31.3 | 27.7 | 27.5 | 27.5 | 27.5 | 28.1 |
| 7 | 47.6 | 47.6 | 47.7 | 47.7 | 47.7 | 47.7 | 26 | 23.1 | 23.1 | 17.3 | 17.4 | 15.4 | 15.3 |
| 8 | 49.2 | 49.4 | 49.3 | 49.3 | 49.2 | 49.2 | 27 | 28.9 | 28.6 | 19.2 | 19.4 | 19.4 | 18.9 |
| 9 | 204.9 | 205.1 | 205.3 | 205.8 | 205.4 | 205.5 | 28 | 175.5 | 175.3 | 87.0 | 84.4 | 84.3 | 86.9 |
| 10 | 193.3 | 193.2 | 193.4 | 193.4 | 193.4 | 193.4 | 29 | 72.0 | 83.1 | 83.0 | 72.1 | ||
| 11 | 136.5 | 136.9 | 136.9 | 136.9 | 136.9 | 136.8 | 30 | 24.9 | 20.6 | 20.6 | 24.7 | ||
| 12 | 128.1 | 128.0 | 128.1 | 128.1 | 128.1 | 128.1 | 31 | 26.2 | 21.1 | 21.1 | 25.8 | ||
| 13 | 128.1 | 127.9 | 127.9 | 127.9 | 127.9 | 127.9 | 32 | 29.0 | 28.9 | 29.0 | 28.9 | 28.9 | 28.9 |
| 14 | 132.1 | 132.1 | 131.9 | 132.0 | 132.0 | 132.0 | 33 | 124.4 | 124.0 | 124.3 | 124.3 | 124.3 | 124.2 |
| 15 | 128.1 | 127.9 | 127.9 | 127.9 | 127.9 | 127.9 | 34 | 132.8 | 133.2 | 132.9 | 133.0 | 133.0 | 133.0 |
| 16 | 128.1 | 128.0 | 128.1 | 128.1 | 128.1 | 128.1 | 35 | 25.8 | 25.8 | 25.8 | 25.8 | 25.8 | 26.1 |
| 17 | 22.4 | 22.3 | 22.4 | 22.4 | 22.3 | 22.3 | 36 | 17.7 | 17.8 | 17.7 | 17.7 | 17.8 | 17.8 |
| 18 | 119.0 | 119.2 | 119.6 | 119.5 | 119.4 | 119.4 | 37 | 22.2 | 22.2 | 22.3 | 22.2 | 22.3 | 22.3 |
| 19 | 133.4 | 133.2 | 132.6 | 132.6 | 132.9 | 132.8 | 38 | 26.9 | 26.9 | 27.0 | 26.9 | 26.9 | 26.9 |
Figure 2(a) Selected 2D NMR correlations for the core structures of 1–6; (b) Newman projections for C-24/C-23 of 1–6; (c) key NOESY correlations for the 1,2-dioxane ring of 3.
Figure 3(a) Energy profiles displayed for the torsion angle of C-23/C-24 of compound 1; (b) Three stable conformations of compound 1 showing the rotation of C-23/C-24; (c) Abbreviated Newman drawing of C-23/C-24 of 1.
Figure 4Calculated 13C NMR data for 4 and 5.
Figure 5Calculated ECD for models (A,B) and the experimental ECD spectra of 1–6.
Cytotoxic Activities of 1–7 (IC50 in μM).
| Compounds | HL-60 | SMMC-7721 | A-549 | MCF-7 | SW480 | BEAS-2B |
|---|---|---|---|---|---|---|
| 1 | >40.00 | >40.00 | >40.00 | >40.00 | >40.00 | – |
| 2 | >40.00 | >40.00 | >40.00 | >40.00 | >40.00 | – |
| 3 | 0.56 | 0.58 | 0.53 | 0.88 | 2.49 | 1.50 |
| 4 | 1.67 | 2.15 | 2.13 | 2.73 | 3.00 | 2.71 |
| 5 | 3.03 | 11.30 | 11.13 | 11.54 | 13.59 | 15.77 |
| 6 | 1.42 | 2.28 | 1.89 | 1.66 | 2.90 | 3.04 |
| 7 | 15.52 | 18.36 | 15.19 | 5.72 | 20.10 | 17.08 |
| DDP | 1.17 | 6.43 | 9.24 | 15.86 | 13.42 | 11.11 |
aThe IC50 value of compound 3 against NB4 cell was 0.63 μM.
bDDP (cis-platin) was used as a positive control; “–” not tested.
Figure 6Compound 3 induces apoptosis in leukemia cells.
(A) After 48 h treatment, cell apoptosis was determined by Annexin V-FITC and PI staining using flow cytometric analysis. Cells in the lower right quadrant indicate early apoptotic cells, and cells in the upper right quadrant indicate late apoptotic cells. (B) Columns, means of three different experiments; bars, SD, *P < 0.05, **P < 0.01 vs control group. (C) Western blot analysis for PARP, Bcl-2, Bcl-xl, Bak and caspase-3 levels, β-Actin was used as a loading control. (D) The relative density compared with β-Actin of each protein was detected by Image J, data are presented as the means of three experiments, bars, SD, *P < 0.05, **P < 0.01 vs control group.